| Market Capitalization (Millions $) |
752 |
| Shares
Outstanding (Millions) |
160 |
| Employees |
6,500 |
| Revenues (TTM) (Millions $) |
2,380 |
| Net Income (TTM) (Millions $) |
39 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
47 |
Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc. is a global pharmaceutical company that specializes in the development, manufacture, and distribution of high-quality generic and branded pharmaceutical products. The company was founded in 2005 by Chirag and Chintu Patel, and is headquartered in Bridgewater, New Jersey, United States.
Amneal has a broad portfolio of products that spans across various therapeutic areas, including CNS disorders, gastrointestinal disorders, cardiovascular diseases, and pain management. The company's products are distributed in more than 150 countries worldwide, through a combination of direct sales, strategic partnerships, and licensing agreements.
Amneal Pharmaceuticals has several manufacturing facilities that operate under strict quality control guidelines and adhere to international regulatory standards. The company's manufacturing facilities are located in the United States, India, Germany, the United Kingdom, and Ireland.
The company has a strong research and development (R&D) pipeline that focuses on developing novel pharmaceutical products using innovative delivery technologies. The R&D team consists of experienced scientists and researchers who work in state-of-the-art laboratories and collaborate with academic institutions and other pharmaceutical companies to develop new and innovative products.
Amneal Pharmaceuticals has received numerous awards and recognitions for its contribution to the pharmaceutical industry. In 2020, the company was named "Generics Company of the Year" by the Generic Pharmaceutical Association (GPhA) and ranked #331 in the Fortune 500 list.
The company's mission is to improve patient health by providing high-quality, affordable pharmaceutical products to people around the world. The company is committed to sustainability and ethical business practices, and has a strong corporate social responsibility program that supports community development, education, and environmental conservation initiatives.
In summary, Amneal Pharmaceuticals Inc. is a global pharmaceutical company that specializes in the development, manufacture, and distribution of high-quality generic and branded pharmaceutical products. The company has a broad portfolio of products that are distributed in more than 150 countries worldwide, and has a strong research and development pipeline that focuses on developing innovative pharmaceutical products. The company is committed to sustainability and ethical business practices, and has a strong corporate social responsibility program.
Company Address: 400 Crossing Boulevard, Bridgewater 8807 NJ
Company Phone Number: 947-3120 Stock Exchange / Ticker: NYSE AMRX
| AMRX is expected to report next financial results on March 02, 2024. |
|
|
17.06%